head and neck cancer

First Presentation of Early Data for Pembrolizumab (MK-3475), Merck’s Investigational Anti-PD-1 Antibody, in Advanced Head and Neck Cancer at ASCO 2014
Yahoo/BusinessWire
Sun, 06/1/14 - 12:18 pm
Pembrolizumab
Merck
head and neck cancer
Oncolytics Biotech reports tumor stabilization or shrinkage in REOLYSIN study
The Fly on the Wall
Tue, 04/8/14 - 08:11 am
Oncolytics
Reolysin
head and neck cancer
Cel-Sci's Multikine - Potential 21st Century Superdrug
Seeking Alpha
Fri, 03/14/14 - 08:40 am
Cel-Sci
head and neck cancer
Multikine
ImmunoGen Offers New Hope For Treatment Of Subtypes Of Squamous Cell Carcinomas And Other Cancers
Seeking Alpha
Sun, 04/14/13 - 12:16 pm
non-small cell lung cancer
Immunogen
IMGN289
head and neck cancer
Pilot Study in Patients with Head and Neck Cancer Finds That Derma Sciences’ MEDIHONEY® Reduces Hospital Stays in the U.K.
Thu, 09/20/12 - 10:43 pm
research
patient
head and neck cancer
Derma Sciences
Medihoney
UK
Oncolytics expands enrollment for cancer drug late-stage trial
Reuters
Thu, 09/13/12 - 09:49 am
head and neck cancer
Oncolytics
Reolysin
Cel-Sci Offers Huge Potential Gains With Revolutionary Immunotherapy Anti-Cancer Drug
Seeking Alpha
Tue, 03/13/12 - 11:25 am
Cel-Sci
Teva Pharmaceuticals
Multikine
head and neck cancer
SciClone Pharmaceuticals halts mid-stage study of potential drug due to poor results
Yahoo/AP
Fri, 03/2/12 - 09:49 am
SciClone
head and neck cancer
SCV-07
oral mucositis
CEL-SCI says Multikine Phase III trial launched in dozens of hospitals
The Fly on the Wall
Mon, 01/23/12 - 11:25 am
Cel-Sci
Multikine
head and neck cancer
CEL-SCI Corporation Releases Letter to Shareholders
Yahoo/BusinessWire
Sat, 01/21/12 - 01:08 pm
Cel-Sci
Multikine
head and neck cancer
Bristol-Myers Approved to Market Erbitux for Wider Cancer Use
Bloomberg
Mon, 11/7/11 - 09:15 pm
Erbitux
Bristol-Myers Squibb
ImClone
Eli Lilly
head and neck cancer
10 Promising Therapeutic Vaccines
Fierce Vaccines
Thu, 10/27/11 - 01:40 pm
vaccines
ICT-107
glioblastoma
ImmunoCellular
VGX-3100
Inovio
cervical cancer
MAGE-A3
GSK
skin cancer
lung cancer
NeuVax
breast cancer
RXi Pharmaceuticals
Antigen Express
AE37
Nexvax2
celiac disease
ImmusanT
ADXS-HPV
head and neck cancer
Advaxis
GI-4000
GlobeImmune
pancreatic cancer
PEV7
Pevion Biotech
CEL-SCI gets Israeli nod to commence phase III trial of multikine in head and neck cancer
pharmabiz
Sat, 04/2/11 - 11:15 am
Cel-Sci
Multikine
head and neck cancer
CEL-SCI Investors Cheer a Bit Too Loudly
Motley Fool
Fri, 12/31/10 - 11:27 am
Cel-Sci
Multikine
head and neck cancer
Eli Lilly Scraps Late-Stage Head and Neck Cancer Drug: Biotech's Latest Tribulations
Seeking Alpha
Sun, 10/17/10 - 11:57 am
Eli Lilly
Alimta
squamous cell cancer
head and neck cancer
Lilly drops Alimta in head/neck cancer, test fails
Reuters
Mon, 10/11/10 - 11:15 am
head and neck cancer
Eli Lilly
Alimta
Amgen: Vectibix fails in head and neck cancer test
Yahoo/AP
Wed, 08/11/10 - 11:31 am
head and neck cancer
Amgen
Vectibix
Boehringer Ingelheim to Present New Data Regarding Its Investigational Compound BIBW 2992 in Head and Neck Cancer
PR-USA
Sun, 05/23/10 - 12:06 pm
Boehringer Ingelheim
head and neck cancer
BIBW 2992

Pages